During the past decade, Community Research Initiative of New England conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 13 clinical trials were completed, i.e. on average, 216.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Research Initiative of New England" #1 sponsor was "Gilead Sciences" with 22 trials, followed by "Community Research Initiative of New England" with 8 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored, "Glaxo Wellcome" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Research Initiative of New England" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Tibotec Pharmaceutical Limited" with 2 trials as a collaborator and "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Community Research Initiative of New England" are "HIV Infections" (46 trials), "HIV" (8 trials), "HIV-1 Infection" (7 trials), "HIV Infection" (3 trials) and "Acquired Immunodeficiency Syndrome" (2 trials). Many other conditions were trialed in "Community Research Initiative of New England" in a lesser frequency.

Most popular intervention types in "Community Research Initiative of New England" are "Drug" (61 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (10 trials), "Stavudine" (9 trials), "Zidovudine" (6 trials), "Nelfinavir mesylate" (5 trials) and "Efavirenz" (4 trials). Other intervention names were less common.

The vast majority of trials in "Community Research Initiative of New England" are 64 trials for "All" genders.

Currently, there are NaN active trials in "Community Research Initiative of New England". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Community Research Initiative of New England, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Community Research Initiative of New England, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 4 trials that are defined as “Not Applicable".